Range
11.66 - 12.06
Vol / Avg.
65.7K/118K
Div / Yield
-
52 Wk
9.71 - 21.4
Mkt Cap
373.8M
Payout Ratio
-
Open
11.84
P/E
-
EPS
-0.82
Shares
31.8M
Outstanding
31.8M
Total Float
-
Benzinga - Jun 3, 2021, 10:27AM
Benzinga - May 18, 2021, 7:44AM
Benzinga - May 17, 2021, 7:15AM
Benzinga - Apr 29, 2021, 8:56AM
Benzinga - Apr 23, 2021, 12:44PM
Benzinga - Apr 23, 2021, 7:13AM
Benzinga - Apr 14, 2021, 10:17AM
Benzinga - Apr 14, 2021, 7:11AM
Benzinga - Apr 8, 2021, 8:38AM
Benzinga - Apr 8, 2021, 7:05AM
Benzinga - Mar 12, 2021, 6:47AM
Benzinga - Mar 11, 2021, 4:33PM
Benzinga - Mar 10, 2021, 7:09AM
Benzinga - Feb 10, 2021, 7:53AM
Benzinga - Feb 9, 2021, 4:05PM
Benzinga - Nov 5, 2020, 5:44PM
Benzinga - Nov 4, 2020, 6:51AM
Benzinga - Oct 26, 2020, 4:25PM
Benzinga - Oct 22, 2020, 7:05AM
Benzinga - Oct 16, 2020, 5:42AM
load more
Sector: Health Care.Industry: Biotechnology
Adicet Bio Inc is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-24
REV
Q1 2021Est.ActualSurprise
EPS-0.820
REV-3.981M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ACETAdicet Bio-1.34%373.8M

Adicet Bio Frequently Asked Questions

Q

How do I buy Adicet Bio (ACET) stock?

A

You can purchase shares of Adicet Bio (NASDAQ: ACET) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adicet Bio's (ACET) competitors?

A

Other companies in Adicet Bio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), 89bio (NASDAQ:ETNB) and Jounce Therapeutics (NASDAQ:JNCE).

Q

What is the target price for Adicet Bio (ACET) stock?

A

The latest price target for Adicet Bio (NASDAQ: ACET) was reported by BTIG on May 18, 2021. The analyst firm set a price target for 34.00 expecting ACET to rise to within 12 months (a possible 189.36% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Adicet Bio (ACET)?

A

The stock price for Adicet Bio (NASDAQ: ACET) is $11.75 last updated Fri Jun 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Adicet Bio (ACET) pay a dividend?

A

There are no upcoming dividends for Adicet Bio. The last dividend paid out to investors was $0.01 on September 21, 2018.

Q

When is Adicet Bio (NASDAQ:ACET) reporting earnings?

A
Adicet Bio’s Q2 earnings are confirmed for after-market on July 24, 2021.
Q

Is Adicet Bio (ACET) going to split?

A

There is no upcoming split for Adicet Bio.

Q

What sector and industry does Adicet Bio (ACET) operate in?

A

Adicet Bio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.